Brian Elsbernd insider trades

Open-market stock purchases and sales by Brian Elsbernd, Chief Legal Officer at Catalyst Pharmaceuticals, Inc, from SEC Form 4 filings since Dec 2, 2019.

Recent trades

DateStockTradeValue
Jul 15, 2026CPRX Catalyst Pharmaceuticals, IncSold (not open market)$7.6M
Jul 15, 2026CPRX Catalyst Pharmaceuticals, IncSold (not open market)—
Jul 15, 2026CPRX Catalyst Pharmaceuticals, IncSold (not open market)—
Jul 15, 2026CPRX Catalyst Pharmaceuticals, IncSold (not open market)—
Jul 15, 2026CPRX Catalyst Pharmaceuticals, IncSold (not open market)—
Jul 15, 2026CPRX Catalyst Pharmaceuticals, IncSold (not open market)—
Jul 15, 2026CPRX Catalyst Pharmaceuticals, IncSold (not open market)—
Jul 15, 2026CPRX Catalyst Pharmaceuticals, IncSold (not open market)—
Jul 15, 2026CPRX Catalyst Pharmaceuticals, IncSold (not open market)—
Jul 15, 2026CPRX Catalyst Pharmaceuticals, IncSold (not open market)—
Jul 15, 2026CPRX Catalyst Pharmaceuticals, IncSold (not open market)—
Dec 29, 2025CPRX Catalyst Pharmaceuticals, IncSold (not open market)—
Dec 29, 2025CPRX Catalyst Pharmaceuticals, IncBought (not open market)—
Dec 8, 2025CPRX Catalyst Pharmaceuticals, IncSold (not open market)—
Dec 8, 2025CPRX Catalyst Pharmaceuticals, IncBought (not open market)—
Nov 21, 2025CPRX Catalyst Pharmaceuticals, IncSold (not open market)—
Nov 21, 2025CPRX Catalyst Pharmaceuticals, IncBought (not open market)—
Nov 20, 2025CPRX Catalyst Pharmaceuticals, IncBought (not open market)—
Nov 20, 2025CPRX Catalyst Pharmaceuticals, IncBought (not open market)—
Nov 12, 2025CPRX Catalyst Pharmaceuticals, IncSold$908K

Companies traded

  • CPRX Catalyst Pharmaceuticals, Inc: 11 sales, last Jul 15, 2026

Get free alerts when Brian Elsbernd files a new trade →